Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-09-000736
Filing Date
2009-03-13
Accepted
2009-03-13 17:21:05
Documents
13
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-K w73164e10vk.htm 10-K 1460939
2 EX-10.34 w73164exv10w34.htm EX-10.34 65358
3 EX-10.35 w73164exv10w35.htm EX-10.35 65905
4 EX-10.36 w73164exv10w36.htm EX-10.36 66045
5 EX-10.37 w73164exv10w37.htm EX-10.37 66095
6 EX-10.38 w73164exv10w38.htm EX-10.38 66108
7 EX-10.53 w73164exv10w53.htm EX-10.53 60741
8 EX-23.1 w73164exv23w1.htm EX-23.1 1513
9 EX-31.1 w73164exv31w1.htm EX-31.1 8173
10 EX-31.2 w73164exv31w2.htm EX-31.2 8766
11 EX-32.1 w73164exv32w1.htm EX-32.1 3076
12 EX-32.2 w73164exv32w2.htm EX-32.2 3092
13 GRAPHIC w73164w7316401.gif GRAPHIC 10888
  Complete submission text file 0000950133-09-000736.txt   1892460
Mailing Address 20425 SENECA MEADOWS PARKWAY, GERMANTOWN, MD 20876
Business Address 20425 SENECA MEADOWS PARKWAY GERMANTOWN MD 20878 (301) 944-6600
MiddleBrook Pharmaceuticals, Inc. (Filer) CIK: 0001161924 (see all company filings)

EIN.: 522208264 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50414 | Film No.: 09681246
SIC: 2834 Pharmaceutical Preparations